ITGR

NEUTRAL

$84.64 Live

Integer Holdings Corporation · NYSE

Target $93.25 (+10.2%)

$62.0 52W Range $127.06

ITGR Integer Holdings Corporation - Fundamental Analysis

NEUTRAL

Console Chart News

ITGR Stock | Fundamental Analysis & Investment Insights

NYSE • Healthcare • Medical Devices

Current Price Live

$84.64

Analyst Target

$93.25

+10.2% Upside

52W High

$127.06

52W Low

$62.0

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026

Market cap

$2.91B

P/E

29.29

ROE

6.1%

Profit margin

5.5%

Debt/Equity

0.75

Dividend yield

N/A

AI Analysis

AI-powered fundamental assessment

Confidence

85%

Integer Holdings (ITGR) presents a dichotomy between strong forward-looking earnings potential and weak current market sentiment. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock is currently trading almost exactly at its growth-based intrinsic value of $85.26, leaving no margin of safety. While the trailing P/E is high, the Forward P/E of 11.71 and explosive YoY earnings growth of 52.9% suggest a significant valuation correction is underway. However, a bearish technical trend and negative insider sentiment temper the bullish analyst consensus.

Key Strengths

Exceptional short-term liquidity with a Current Ratio of 3.32

Strong earnings acceleration with 52.9% YoY growth

Attractive Forward P/E (11.71) compared to trailing P/E (29.29)

Stable financial health baseline (Piotroski 4/9)

Positive analyst consensus with a target price of $93.25

Key Risks

Lack of margin of safety as price ($84.64) equals intrinsic value ($85.26)

Stagnant revenue growth (5% YoY) suggesting earnings growth is driven by cost-cutting rather than expansion

Bearish technical trend (0/100) and negative insider sentiment

Low Return on Equity (6.11%) relative to growth expectations

Significant 1-year price decline (-31.1%)

AI Fair Value Estimate

Based on comprehensive analysis

$85.5

+1.0% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Moderate

Value

Future

Past

Health

Dividend

AI Verdict

Fairly Valued / Speculative Recovery

Key drivers: Earnings growth, Forward P/E compression, Technical weakness

Confidence

80%

Value

65/100

Ref P/E, PEG, Graham Number

Positives

Forward P/E is very low (11.71)
Price/Book is reasonable at 1.66

Watchpoints

Trades significantly above Graham Number ($57.5)
No margin of safety relative to intrinsic value

Future

75/100

Ref Growth rates

Positives

High YoY earnings growth (52.9%)
Consistent earnings beats in recent quarters

Watchpoints

Low revenue growth (5%)

Past

40/100

Ref Historical trends

Positives

Recent 6-month recovery (+24.5%)

Watchpoints

Poor 1-year performance (-31.1%)
Negative 5-year change (-11.1%)

Health

60/100

Ref Altman Z-Score, Piotroski F-Score

Positives

Strong Current Ratio (3.32)
Manageable Debt/Equity (0.75)

Watchpoints

Piotroski F-Score is only 4/9 (Stable, not Strong)

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

No dividend payments
0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$84.64

Analyst Target

$93.25

Upside/Downside

+10.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ITGR and closest competitors.

Updated 2026-04-28

Company	5Y	3Y	1Y	6M	1M	1W
ITGR Integer Holdings Corporation Primary	-11.1%	+2.8%	-31.1%	+24.5%	-0.6%	-1.1%
CON Concentra Group Holdings Parent, Inc. Peer	+3.3%	+3.3%	+8.6%	+9.8%	+3.7%	-0.2%
TXG 10x Genomics, Inc. Peer	-88.0%	-57.2%	+199.1%	+76.3%	+20.0%	-7.4%
SUPN Supernus Pharmaceuticals, Inc. Peer	+66.0%	+41.6%	+67.1%	+2.4%	+4.3%	+1.4%
ARQT Arcutis Biotherapeutics, Inc. Peer	-30.1%	+98.3%	+53.6%	+31.6%	-14.4%	-5.2%

ITG

Integer Holdings Corporation

Primary

-11.1%

+2.8%

-31.1%

+24.5%

-0.6%

-1.1%

CON

Concentra Group Holdings Parent, Inc.

Peer

+3.3%

+8.6%

+9.8%

+3.7%

-0.2%

TXG

10x Genomics, Inc.

Peer

-88.0%

-57.2%

+199.1%

+76.3%

+20.0%

-7.4%

SUP

Supernus Pharmaceuticals, Inc.

Peer

+66.0%

+41.6%

+67.1%

+2.4%

+4.3%

+1.4%

ARQ

Arcutis Biotherapeutics, Inc.

Peer

-30.1%

+98.3%

+53.6%

+31.6%

-14.4%

-5.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

29.29

11.71

1.4

1.66

1.57

2.27

11.17

$2.91B

Profitability

Profit margins and return metrics

Profit Margin 5.55%

Operating Margin 12.79%

Gross Margin 27.39%

ROE 6.11%

ROA 4.75%

Growth

Revenue and earnings growth rates

Revenue Growth +5.0%

Earnings Growth +52.9%

Q/Q Revenue Growth +5.02%

Q/Q Earnings Growth +48.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

0.75

Moderate

Current Ratio

3.32

Strong

Quick Ratio

2.05

Excellent

Cash/Share

$0.5

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue

$0.5B

Gross Margin

26.4%

Op. Margin

11.6%

Net Margin

10.3%

Total Assets

$3.4B

Liabilities

$1.7B

Equity

$1.7B

Debt/Equity

0.95x

Operating CF

$0.1B

CapEx

$-0.0B

Free Cash Flow

$0.0B

FCF Yield

52%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-30

$N/A

2026-02-19

$1.76

+3.6% surprise

2025-10-23

$1.79

+6.8% surprise

2025-07-24

$1.55

-0.1% surprise

Healthcare Sector Comparison

Comparing ITGR against 564 companies in the Healthcare sector (36 bullish, 168 neutral, 360 bearish)

P/E Ratio

29.29

This Stock

74.29

Sector Avg

-60.6% (Discount)

Return on Equity (ROE)

6.11%

This Stock

-87.3%

Sector Avg

-107.0% (Below Avg)

Profit Margin

5.55%

This Stock

-16.1%

Sector Avg

-134.4% (Weaker)

Debt to Equity

0.75

This Stock

2.65

Sector Avg

-71.5% (Less Debt)

Revenue Growth

5.0%

This Stock

123.13%

Sector Avg

-95.9% (Slower)

Current Ratio

3.32

This Stock

4.46

Sector Avg

-25.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
ITGR Integer Holdings Corporation	NEUTRAL	$2.91B	29.29	6.1%	5.5%	$84.64
CON Concentra Group Holdings...	NEUTRAL	$2.93B	17.55	48.1%	7.7%	$22.82	Compare
TXG 10x Genomics, Inc.	NEUTRAL	$2.93B	-	-5.8%	-6.8%	$22.97	Compare
SUPN Supernus Pharmaceuticals, Inc.	NEUTRAL	$2.96B	-	-3.7%	-5.4%	$51.39	Compare
ARQT Arcutis Biotherapeutics, Inc.	BEARISH	$2.82B	-	-9.3%	-4.3%	$22.75	Compare

ITGR Integer Holdings...

NEUTRAL

Mkt Cap

$2.9B

P/E

29.3

ROE

6.1%

Price

$84.64

Compare with ITGR

TXG 10x Genomics, Inc.

Compare with ITGR

Compare with ITGR

Compare with ITGR

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date	Insider	Position	Transaction	Shares	Value
2026-03-31	HARRIS JOHN A	Officer	Stock Award	3,837	-
2026-03-24	BLACKWOOD LINDSAY K.	General Counsel	Stock Award	3,483	-
2026-03-24	CARR TERENCE	Officer	Stock Award	1,350	-
2026-03-13	THOMAS TOMMY P.	Officer	Sale	825	$70,125
2026-03-12	KAPITO AARON J.	Director	Stock Award	410	-
2026-03-12	FLANAGAN JAMES FRANCIS	Director	Stock Award	410	-
2026-02-24	KHALES PAYMAN	Chief Executive Officer	Stock Award	43,060	-
2026-02-20	THOR KIRK K	Officer	Stock Award	9,025	-
2026-02-20	THOMAS TOMMY P.	Officer	Stock Award	1,862	-
2026-02-20	KHALES PAYMAN	Chief Executive Officer	Stock Award	14,905	-
2026-02-20	SENN ANDREW	Officer	Stock Award	4,720	-
2026-02-20	SMITH DIRON	Chief Financial Officer	Stock Award	1,615	-
2026-02-20	STEPHENS JIM	Officer	Stock Award	2,691	-
2026-01-20	THOR KIRK K	Officer	Stock Award	2,061	-
2026-01-20	THOMAS TOMMY P.	Officer	Stock Award	795	-

HARRIS JOHN A

Officer

Stock Award

2026-03-31

3,837 shares

BLACKWOOD LINDSAY K.

General Counsel

Stock Award

2026-03-24

3,483 shares

CARR TERENCE

Officer

Stock Award

2026-03-24

1,350 shares

THOMAS TOMMY P.

Officer

Sell

2026-03-13

825 shares · $70,125

KAPITO AARON J.

Director

Stock Award

2026-03-12

410 shares

FLANAGAN JAMES FRANCIS

Director

Stock Award

2026-03-12

410 shares

KHALES PAYMAN

Chief Executive Officer

Stock Award

2026-02-24

43,060 shares

THOR KIRK K

Officer

Stock Award

2026-02-20

9,025 shares

THOMAS TOMMY P.

Officer

Stock Award

2026-02-20

1,862 shares

KHALES PAYMAN

Chief Executive Officer

Stock Award

2026-02-20

14,905 shares

SENN ANDREW

Officer

Stock Award

2026-02-20

4,720 shares

SMITH DIRON

Chief Financial Officer

Stock Award

2026-02-20

1,615 shares

STEPHENS JIM

Officer

Stock Award

2026-02-20

2,691 shares

THOR KIRK K

Officer

Stock Award

2026-01-20

2,061 shares

THOMAS TOMMY P.

Officer

Stock Award

2026-01-20

795 shares

Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A

2026-04-06

ITGR filed a definitive proxy statement on April 6, 2026, providing shareholders with necessary information and voting materials for its upcoming annual meeting.

8-K

FORM 8-K

2026-03-12

10-K

2026-02-23

ITGR filed its annual 10-K report on February 23, 2026, which includes management's discussion and analysis of its financial condition and results of operations. The filing outlines the company's business operations and identifies key risk factors, including specific disclosures regarding cybersecurity.

8-K

FORM 8-K

2026-02-19

Integrity Services (ITGR) filed an 8-K on February 19, 2026, likely to announce its fourth-quarter and full-year financial results.

8-K

FORM 8-K

2025-11-04

8-K

FORM 8-K

2025-10-24

10-Q

2025-10-23

ITGR filed its 10-Q on October 23, 2025. While the filing includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk disclosures were provided in the available excerpt.

8-K

FORM 8-K

2025-10-23

10-Q

2025-07-24

ITGR filed its 10-Q on July 24, 2025. While specific financial highlights were not provided in the excerpt, the filing includes a dedicated section detailing the company's risk factors.

8-K

FORM 8-K

2025-07-24

Integrity Services (ITGR) filed an 8-K on July 24, 2025, likely to announce its second-quarter financial results.

8-K

FORM 8-K

2025-07-10

8-K

FORM 8-K

2025-07-02

8-K

2025-05-28

8-K

FORM 8-K

2025-04-24

8-K

FORM 8-K

2025-04-24

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus

BUY

8 analysts

Citigroup

2026-02-20

Maintains

Neutral Neutral

Wells Fargo

2026-02-20

Maintains

Equal-Weight Equal-Weight

Benchmark

2026-02-20

Hold Buy

Truist Securities

2026-02-20

Maintains

Buy Buy

Truist Securities

2025-12-18

Maintains

Buy Buy

Citigroup

2025-12-11

Maintains

Neutral Neutral

Truist Securities

2025-11-24

Maintains

Buy Buy

Citigroup

2025-11-03

Maintains

Neutral Neutral

Past News Coverage

Recent headlines mentioning ITGR from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

ITGR

ITGR Integer Holdings Corporation - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Quarterly Earnings History

Healthcare Sector Comparison

Similar Companies

Recent Insider Trading

SEC Filings

Wall Street Analysts

Past News Coverage

Wait — Don't Miss Out!